Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Bolus Interleukin-2 in Previously Treated Lung Cancer

NCT00003090 is registered in ClinicalTrials.gov with Cancer Biotherapy Research Group as lead sponsor.

NCT NCT00003090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Bolus Interleukin-2 in Previously Treated Lung Cancer
Lead sponsor
Cancer Biotherapy Research Group
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 1996
Completion date
Not reported
Enrollment
30 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer